is a topic covered in the Davis's Drug Guide
To view the entire topic, please sign in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Quiring, Courtney, et al. "Reslizumab." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110405/all/reslizumab.
Quiring C, Sanoski CA, Vallerand AH. Reslizumab. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110405/all/reslizumab. Accessed October 23, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Reslizumab. In Davis's Drug Guide. Available from https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110405/all/reslizumab
Quiring C, Sanoski CA, Vallerand AH. Reslizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 October 23]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110405/all/reslizumab.
TY - ELEC
T1 - reslizumab
ID - 110405
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110405/all/reslizumab
PB - F.A. Davis Company
ET - 16
DB - Emergency Central
DP - Unbound Medicine